The Skeletal Muscle–Metabolism Axis in Prostate-Cancer Therapy
- 6 December 2012
- journal article
- letter
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 367 (23) , 2257-2258
Abstract
Basaria and Bhasin (Sept. 6 issue)1 report that men with prostate cancer who are receiving androgen-deprivation therapy have multiple adverse events. The authors included follistatin and irisin between the main targets of investigation to prevent and treat the metabolic side effects associated with androgen-deprivation therapy. It has been shown that exercise induces a marked increase in plasma and muscle follistatin and irisin.2-4 Follistatin expression changes in both the muscle and fat of diabetic rats and can be modulated by exercise.5 Concentrations of irisin increase significantly after exercise in both mice and humans, and irisin levels in the blood are correlated with irisin messenger RNA levels in muscle tissue.4 All these facts underscore the importance of exercise with regard to the overexpression of both myokines and, therefore, with regard to the prevention and treatment of sarcopenia, frailty, and the cardiometabolic complications of androgen-deprivation therapy. Although it might not be feasible for some patients, physicians should strongly recommend exercise or simple physical activity as an adjuvant therapy for patients who have prostate cancer and are receiving androgen-deprivation therapy.Keywords
This publication has 9 references indexed in Scilit:
- Targeting the Skeletal Muscle–Metabolism Axis in Prostate-Cancer TherapyNew England Journal of Medicine, 2012
- Beige Adipocytes Are a Distinct Type of Thermogenic Fat Cell in Mouse and HumanCell, 2012
- Expression of myostatin, myostatin receptors and follistatin in diabetic rats submitted to exerciseClinical and Experimental Pharmacology and Physiology, 2012
- A PGC1-α-dependent myokine that drives brown-fat-like development of white fat and thermogenesisNature, 2012
- Exercise Induces a Marked Increase in Plasma Follistatin: Evidence That Follistatin Is a Contraction-Induced HepatokineEndocrinology, 2011
- Randomized Controlled Trial of Resistance or Aerobic Exercise in Men Receiving Radiation Therapy for Prostate CancerJournal of Clinical Oncology, 2009
- Androgen Deprivation Therapy, Insulin Resistance, and Cardiovascular Mortality: An Inconvenient TruthJournal of Andrology, 2008
- Falls and Physical Performance Deficits in Older Patients With Prostate Cancer Undergoing Androgen Deprivation TherapyUrology, 2008
- Long‐term effects of androgen deprivation therapy in prostate cancer patientsClinical Endocrinology, 2002